Source: The Next Web
Dognosis exploits a measurable biological reality—dogs can detect volatile organic compounds in breath—but outsources pattern recognition to machine learning rather than relying on animal cognition alone. This allows the approach to scale beyond the limitations of training and maintaining working dogs. The hybrid model sidesteps regulatory and deployment friction by positioning itself as a validation layer: dogs establish proof of concept and train the AI, then the algorithm handles throughput. The result makes early cancer detection viable in resource-constrained healthcare markets like India.